About Pakistan


 Neuro-Oncology Webinar Series (NOWS)

Glioblastoma Multiforme: Current Medical Treatments and Future Directions

About Speaker:
Olivier Rixe, MD, PhD, is an internationally recognized medical oncologist in the field of developmental therapeutics and brain tumors. Dr. Rixe has received numerous awards, which include the Merit Order (Ordre National du Merite) for cancer research from the President of France, Jacques Chirac. While working as an oncologist, he has had nearly 300 publications. He has held a senior position in academia for the past 25 years where he has conducted clinical trials in patients with resistant tumors, including many translational studies, testing new therapeutic strategies with chemotherapy, gene therapy, targeted therapy and immunotherapy. He served as a senior investigator in the Phase 1 Unit at Gustave Roussy Institute in Villejuif, France. Dr. Rixe was appointed Professor of Medical Oncology in 2003 at Pierre and Marie Curie University (Paris 6). In 2008, Dr. Rixe joined the Medicine Oncology Branch at the NCI in Bethesda, MD as a staff clinician. In 2009, Dr. Rixe came to the University of Cincinnati (UC) as a Professor of Medicine and the John and Gladys Strauss Chair in cancer research and assumed the position of both Director of the Experimental Therapeutics Program and Research Director of the UC Brain Tumor Center. More recently, he was the co-director of the brain tumor program with Dr Omar Chohan at the NCI-designated cancer center at University of New Mexico.
He is currently Vice President at Daiichi Sankyo, NJ for early drug development.





Official journals of PASNO are



[Page: 21 & 149]

Copyright 2020-21 PASNO. All Rights Reserved.